Chaperone substrate provides missing link for cancer drug discovery

Katherine M Byrd1, Brian S J Blagg1

  • 1From the Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46545.

Insights

Researchers identified two inhibitors of apoptosis proteins (IAPs) as specific targets of heat shock protein 70 (Hsp70). This discovery provides crucial biomarkers for monitoring Hsp70 inhibition in cancer drug development.

Area of Science:

  • Molecular biology
  • Cancer research
  • Biochemistry

Background:

  • Heat shock proteins (Hsp70 and Hsp90) are overexpressed in various cancers.
  • These chaperones are recognized as significant targets for cancer chemotherapeutics.
  • A lack of specific biomarkers for Hsp70 inhibition has hindered the development of targeted therapies.

Purpose of the Study:

  • To identify specific client substrates of Hsp70.
  • To establish reliable biomolecular readouts for monitoring Hsp70 activity.
  • To facilitate the development of novel Hsp70-specific inhibitors for cancer treatment.

Main Methods:

  • The study focused on identifying specific protein interactions with Hsp70.
  • Investigated the role of inhibitors of apoptosis proteins (IAPs) in relation to Hsp70.
  • Utilized biochemical assays to validate Hsp70 client substrates.

Main Results:

  • Two specific inhibitors of apoptosis proteins (IAPs) were identified as direct client substrates of Hsp70.
  • This finding establishes IAPs as potential biomarkers for Hsp70 activity.
  • The results provide a foundation for developing assays to assess Hsp70 inhibition.

Conclusions:

  • The identification of IAPs as Hsp70 client substrates offers a novel approach to monitor Hsp70 inhibition.
  • These findings pave the way for the development of targeted cancer therapies focused on Hsp70.
  • The study contributes to a better understanding of chaperone networks in cancer biology.

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.0K
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
20.0K
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

15.1K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.7K
X-linked Traits01:19

X-linked Traits

In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
59.0K
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
109.3K